{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:59:40Z","timestamp":1792133980146,"version":"4.4.0"},"reference-count":177,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/20\/17\/35050"],"award-info":[{"award-number":["PG\/20\/17\/35050"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000294","name":"Medical Research Scotland","doi-asserted-by":"publisher","award":["PHD-50408-2021"],"award-info":[{"award-number":["PHD-50408-2021"]}],"id":[{"id":"10.13039\/501100000294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000327","name":"Heart Research UK","doi-asserted-by":"publisher","award":["SCOT22 \u2013 100006 2311"],"award-info":[{"award-number":["SCOT22 \u2013 100006 2311"]}],"id":[{"id":"10.13039\/501100000327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000849","name":"NC3Rs","doi-asserted-by":"publisher","award":["NC\/W001.810\/1"],"award-info":[{"award-number":["NC\/W001.810\/1"]}],"id":[{"id":"10.13039\/501100000849","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1156506"],"award-info":[{"award-number":["1156506"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jtha.2023.09.012","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T15:23:00Z","timestamp":1700666580000},"page":"3304-3316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["The fibrinolysis renaissance"],"prefix":"10.1016","volume":"21","author":[{"given":"Nicola J.","family":"Mutch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Medcalf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.09.012_bib1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bjh.15062","article-title":"Haemostasis and innate immunity - a complementary relationship: a review of the intricate relationship between coagulation and complement pathways","volume":"180","author":"Keragala","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.09.012_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12862-019-1353-z","article-title":"Origin and diversification of the plasminogen activation system among chordates","volume":"19","author":"Chana-Munoz","year":"2019","journal-title":"BMC Evol Biol"},{"key":"10.1016\/j.jtha.2023.09.012_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073406","article-title":"Fibrinolysis: a primordial system linked to the immune response","volume":"22","author":"Medcalf","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2023.09.012_bib4","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1538-7836.2007.02430.x","article-title":"TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots","volume":"5","author":"Mutch","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/jcp.37.7.772","article-title":"Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator","volume":"37","author":"Booth","year":"1984","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jtha.2023.09.012_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jth.13261","article-title":"Structure-function relationships in thrombin-activatable fibrinolysis inhibitor","volume":"14","author":"Plug","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib7","first-page":"661","article-title":"Fibrinolyse dans le sang","volume":"5","author":"Dastre","year":"1893","journal-title":"Arch Physiol"},{"key":"10.1016\/j.jtha.2023.09.012_bib8","first-page":"327","article-title":"690","volume":"55","author":"Delezene","year":"1903","journal-title":"CR Soc Biol Paris"},{"key":"10.1016\/j.jtha.2023.09.012_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1084\/jem.58.4.485","article-title":"The fibrinolytic activity of hemolytic Streptococci","volume":"58","author":"Tillett","year":"1933","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jtha.2023.09.012_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4049\/jimmunol.42.2.109","article-title":"A\u00a0factor in normal human blood which particiaptes in streptococcal fibrinolysis","volume":"42","author":"Milstone","year":"1941","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jtha.2023.09.012_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1085\/jgp.28.6.559","article-title":"A\u00a0proteolytic enzyme of serum: characterization, activation, and reaction with inhibitors","volume":"28","author":"Christensen","year":"1945","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.jtha.2023.09.012_bib12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0140-6736(46)91017-3","article-title":"Observations on fibrinolysis; plasminogen, plasmin, and antiplasmin content of human blood","volume":"2","author":"Macfarlane","year":"1946","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.09.012_bib13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/159681b0","article-title":"Fibrinolysis in the animal organism","volume":"159","author":"Astrup","year":"1947","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2023.09.012_bib14","first-page":"768","article-title":"Urokinase: an activator of plasma profibrinolysin extracted from urine","volume":"171","author":"Sobel","year":"1952","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jtha.2023.09.012_bib15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3109\/00365516309051342","article-title":"Selective inhibition in human pregnancy blood of urokinase induced fibrinolysis","volume":"15","author":"Brakman","year":"1963","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jtha.2023.09.012_bib16","series-title":"The physiological inhibitors of coagulation and fibrinolysis","first-page":"189","article-title":"Inhibitors of plasminogen activation distinct from the other plasma protease inhibitors - a review","author":"Hedner","year":"1979"},{"key":"10.1016\/j.jtha.2023.09.012_bib17","series-title":"The physiological inhibitors of coagulation and fibrinolysis","first-page":"199","article-title":"Inhibitors of plasminogen activation present in human plasma","author":"Gallimore","year":"1979"},{"key":"10.1016\/j.jtha.2023.09.012_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1432-1033.1976.tb10875.x","article-title":"Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma","volume":"69","author":"Collen","year":"1976","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jtha.2023.09.012_bib19","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1016\/S0021-9258(17)33045-4","article-title":"Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis","volume":"251","author":"Moroi","year":"1976","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/bj1590545","article-title":"The primary inhibitor of plasmin in human plasma","volume":"159","author":"Mullertz","year":"1976","journal-title":"Biochem J"},{"key":"10.1016\/j.jtha.2023.09.012_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood.V64.4.907.907","article-title":"Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma","volume":"64","author":"Kruithof","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0049-3848(83)90407-3","article-title":"Evidence for a rapid inhibitor to tissue plasminogen activator in plasma","volume":"31","author":"Chmielewska","year":"1983","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.09.012_bib23","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1073\/pnas.80.10.2956","article-title":"Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells","volume":"80","author":"Loskutoff","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2023.09.012_bib24","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jcp.38.7.825","article-title":"Platelet release protein which inhibits plasminogen activators","volume":"38","author":"Booth","year":"1985","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jtha.2023.09.012_bib25","doi-asserted-by":"crossref","first-page":"14914","DOI":"10.1016\/S0021-9258(17)42691-3","article-title":"Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells","volume":"259","author":"van Mourik","year":"1984","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/oxfordjournals.jbchem.a129257","article-title":"Partial purification and properties of urokinase inhibitor from human placenta","volume":"67","author":"Kawano","year":"1970","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.jtha.2023.09.012_bib27","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1172\/JCI112761","article-title":"cDNA cloning of human plasminogen activator-inhibitor from endothelial cells","volume":"78","author":"Ginsburg","year":"1986","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.09.012_bib28","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1073\/pnas.83.18.6776","article-title":"Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor","volume":"83","author":"Ny","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2023.09.012_bib29","first-page":"4564","article-title":"Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells","volume":"7","author":"Schleuning","year":"1987","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jtha.2023.09.012_bib30","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1021\/bi00178a022","article-title":"Engineering plasminogen activator inhibitor 1 mutants with increased functional stability","volume":"33","author":"Lawrence","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2023.09.012_bib31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1161\/01.RES.67.5.1281","article-title":"Studies of recombinant plasminogen activator inhibitor-1 in rabbits. Pharmacokinetics and evidence for reactivation of latent plasminogen activator inhibitor-1 in\u00a0vivo","volume":"67","author":"Vaughan","year":"1990","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2023.09.012_bib32","doi-asserted-by":"crossref","first-page":"15454","DOI":"10.1016\/S0021-9258(19)37610-0","article-title":"Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin)","volume":"263","author":"Declerck","year":"1988","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nsb943","article-title":"How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration","volume":"10","author":"Zhou","year":"2003","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.jtha.2023.09.012_bib34","doi-asserted-by":"crossref","first-page":"9291","DOI":"10.1016\/S0021-9258(19)86843-6","article-title":"On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin","volume":"254","author":"Wiman","year":"1979","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib35","doi-asserted-by":"crossref","first-page":"24544","DOI":"10.1074\/jbc.M111.229013","article-title":"Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition","volume":"286","author":"Lu","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib36","first-page":"372","article-title":"Synthesis and secretion of the fibrinolytic components, including alpha 2-antiplasmin, by a human hepatoma cell line","volume":"101","author":"Fair","year":"1983","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.jtha.2023.09.012_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2023.09.012_bib38","series-title":"Platelets","first-page":"469","article-title":"The role of platelets in fibrinolysis (Chapter 23)","author":"Mutch","year":"2019"},{"key":"10.1016\/j.jtha.2023.09.012_bib39","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1172\/JCI109671","article-title":"Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor","volume":"65","author":"Sakata","year":"1980","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.09.012_bib40","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1172\/JCI110479","article-title":"Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis","volume":"69","author":"Sakata","year":"1982","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.09.012_bib41","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1538-7836.2010.03963.x","article-title":"Model thrombi formed\u00a0under\u00a0flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis","volume":"8","author":"Mutch","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib42","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/jth.13354","article-title":"Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII","volume":"14","author":"Rijken","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib43","first-page":"11","article-title":"A\u00a0novel role for plasminogen activator inhibitor type-2 as a hypochlorite-resistant serine protease inhibitor and holdase chaperone","author":"Cater","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jtha.2023.09.012_bib44","doi-asserted-by":"crossref","first-page":"43164","DOI":"10.1074\/jbc.M111.245647","article-title":"Association of plasminogen activator inhibitor type 2 (PAI-2) with proteasome within endothelial cells activated with inflammatory stimuli","volume":"286","author":"Boncela","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-0037-1614425","article-title":"Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin","volume":"81","author":"Ritchie","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib46","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/s-0038-1642672","article-title":"The enigma PAI-2. Gene expression, evolutionary and functional aspects","volume":"74","author":"Bachmann","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib47","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1083\/jcb.104.3.705","article-title":"Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells","volume":"104","author":"Genton","year":"1987","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jtha.2023.09.012_bib48","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/s-2007-996035","article-title":"Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy","volume":"24","author":"Astedt","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib49","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1073\/pnas.96.2.686","article-title":"The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival","volume":"96","author":"Dougherty","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2023.09.012_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1432-1033.1988.tb14162.x","article-title":"Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2","volume":"175","author":"Thorsen","year":"1988","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jtha.2023.09.012_bib51","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/jth.12704","article-title":"Is plasminogen activator inhibitor type 2 really a plasminogen activator inhibitor after all?","volume":"12","author":"Gardiner","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib52","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/jth.12657","article-title":"Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice","volume":"12","author":"Siefert","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib53","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/jth.13168","article-title":"Evaluation of and recommendation for the nomenclature of the CPB2 gene product (also known as TAFI and proCPU): communication from the SSC of the ISTH","volume":"13","author":"Foley","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib54","first-page":"277","article-title":"Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N","volume":"27","author":"Hendriks","year":"1989","journal-title":"J\u00a0Clin Chem Clin Biochem"},{"key":"10.1016\/j.jtha.2023.09.012_bib55","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0304-4165(90)90157-R","article-title":"Purification and characterization of a new arginine carboxypeptidase in human serum","volume":"1034","author":"Hendriks","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jtha.2023.09.012_bib56","doi-asserted-by":"crossref","first-page":"21833","DOI":"10.1016\/S0021-9258(18)54713-X","article-title":"Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma","volume":"266","author":"Eaton","year":"1991","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib57","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0006-291X(89)90762-6","article-title":"An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits","volume":"162","author":"Campbell","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jtha.2023.09.012_bib58","doi-asserted-by":"crossref","first-page":"14477","DOI":"10.1074\/jbc.270.24.14477","article-title":"Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor","volume":"270","author":"Bajzar","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib59","doi-asserted-by":"crossref","first-page":"16603","DOI":"10.1074\/jbc.271.28.16603","article-title":"TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex","volume":"271","author":"Bajzar","year":"1996","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib60","doi-asserted-by":"crossref","first-page":"35046","DOI":"10.1074\/jbc.274.49.35046","article-title":"Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans","volume":"274","author":"Mao","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00062752-199809000-00001","article-title":"Fibrinolysis and the plasma carboxypeptidase","volume":"5","author":"Nesheim","year":"1998","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jtha.2023.09.012_bib62","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0038-1650023","article-title":"On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture","volume":"43","author":"Collen","year":"1980","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/excr.1998.4067","article-title":"Loss of cell viability dramatically elevates cell surface plasminogen binding and activation","volume":"242","author":"O'Mullane","year":"1998","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jtha.2023.09.012_bib64","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1182\/blood-2009-02-203448","article-title":"A\u00a0nonfibrin macromolecular cofactor for tPA-mediated plasmin generation following cellular injury","volume":"114","author":"Samson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib65","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.celrep.2012.08.026","article-title":"Nucleocytoplasmic coagulation: an injury-induced aggregation event that disulfide crosslinks proteins and facilitates their removal by plasmin","volume":"2","author":"Samson","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtha.2023.09.012_bib66","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1016\/S0021-9258(18)89264-X","article-title":"Binding and activation of plasminogen on the platelet surface","volume":"260","author":"Miles","year":"1985","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0033-1334483","article-title":"Plasminogen receptors: the first quarter century","volume":"39","author":"Miles","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0049-3848(95)91621-Q","article-title":"Binding of tissue plasminogen activator to endothelial cells. The effect on functional properties. Localization of a ligand in the B-chain of tPA","volume":"77","author":"Cheng","year":"1995","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.09.012_bib69","doi-asserted-by":"crossref","first-page":"42679","DOI":"10.1074\/jbc.M305695200","article-title":"Functional regulation of tissue plasminogen activator on the surface of vascular smooth muscle cells by the type-II transmembrane protein p63 (CKAP4)","volume":"278","author":"Razzaq","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib70","first-page":"269","article-title":"The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface","volume":"376","author":"Behrendt","year":"1995","journal-title":"Biol Chem Hoppe Seyler"},{"key":"10.1016\/j.jtha.2023.09.012_bib71","doi-asserted-by":"crossref","first-page":"14779","DOI":"10.1074\/jbc.271.25.14779","article-title":"Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase","volume":"271","author":"Ellis","year":"1996","journal-title":"J\u00a0Biol Chem"},{"issue":"Pt 1","key":"10.1016\/j.jtha.2023.09.012_bib72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1242\/jcs.113.1.123","article-title":"Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion","volume":"113","author":"Webb","year":"2000","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.jtha.2023.09.012_bib73","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1083\/jcb.144.6.1285","article-title":"A\u00a0role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling","volume":"144","author":"Wei","year":"1999","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jtha.2023.09.012_bib74","doi-asserted-by":"crossref","first-page":"25668","DOI":"10.1016\/S0021-9258(18)47301-2","volume":"269","author":"Nykjaer","year":"1994","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib75","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1093\/emboj\/16.10.2610","article-title":"Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes","volume":"16","author":"Nykjaer","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.jtha.2023.09.012_bib76","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1172\/JCI92880","article-title":"Factor XII and uPAR upregulate neutrophil functions to influence wound healing","volume":"128","author":"Stavrou","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.09.012_bib77","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/S0021-9258(17)41961-2","article-title":"Characterization of plasminogen activation by glycosylphosphatidylinositol-anchored urokinase","volume":"269","author":"Lee","year":"1994","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib78","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/S0021-9258(18)94159-1","article-title":"Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes","volume":"264","author":"Ellis","year":"1989","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib79","doi-asserted-by":"crossref","first-page":"14580","DOI":"10.1016\/S0021-9258(18)98725-9","article-title":"Single chain urokinase. Augmentation of enzymatic activity upon binding to monocytes","volume":"266","author":"Manchanda","year":"1991","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib80","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1538-7836.2010.03813.x","article-title":"Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: a mechanism for stimulation of fibrinolysis by platelets","volume":"8","author":"Baeten","year":"2010","journal-title":"J\u00a0ThrombHaemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib81","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1182\/blood-2009-06-228817","article-title":"Fibrinolytic cross-talk: a new mechanism for plasmin formation","volume":"115","author":"Dejouvencel","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib82","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1182\/blood-2014-06-583070","article-title":"Functional factor XIII-A is exposed on the stimulated platelet surface","volume":"124","author":"Mitchell","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib83","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1182\/blood-2013-04-491290","article-title":"Clot retraction is mediated by factor XIII-dependent fibrin-alphaIIbbeta3-myosin axis in platelet sphingomyelin-rich membrane rafts","volume":"122","author":"Kasahara","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib84","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0036-1597283","article-title":"Platelet-mediated modulation of fibrinolysis","volume":"43","author":"Whyte","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib85","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/blood-2004-04-1439","article-title":"Platelets synthesize large amounts of active plasminogen activator inhibitor 1","volume":"104","author":"Brogren","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib86","article-title":"Functional plasminogen activator inhibitor 1 is retained on the activated platelet membrane following platelet activation","author":"Morrow","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2023.09.012_bib87","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood.V58.6.1069.1069","article-title":"The presence and release of alpha 2-antiplasmin from human platelets","volume":"58","author":"Plow","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib88","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/j.1538-7836.2010.04024.x","article-title":"Secretion and antifibrinolytic function of thrombin-activatable fibrinolysis inhibitor from human platelets","volume":"8","author":"Schadinger","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib89","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1182\/blood-2017-06-789032","article-title":"Endogenous fibrinolysis facilitates clot retraction in\u00a0vivo","volume":"130","author":"Samson","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib90","article-title":"Step up to the platelet: role of platelets in inflammation and infection","author":"Carestia","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.09.012_bib91","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1182\/blood-2014-09-599480","article-title":"Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow","volume":"125","author":"Whyte","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib92","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/blood.2020007263","article-title":"Exposure of plasminogen and a novel plasminogen receptor, Plg-RKT, on activated human and murine platelets","volume":"137","author":"Whyte","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib93","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1111\/jth.14950","article-title":"Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets","volume":"18","author":"Ni","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib94","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/bloodadvances.2020002923","article-title":"Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system","volume":"4","author":"Suzuki","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.09.012_bib95","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1182\/blood-2010-11-316943","article-title":"Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen","volume":"118","author":"Han","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib96","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/blood-2008-03-144279","article-title":"Unique secretory dynamics of tissue plasminogen activator and its modulation by plasminogen activator inhibitor-1 in vascular endothelial cells","volume":"113","author":"Suzuki","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib97","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1182\/blood-2011-05-353912","article-title":"Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cells","volume":"118","author":"Suzuki","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.653655","article-title":"A\u00a0serpin with a finger in many PAIs: PAI-1's central function in thromboinflammation and cardiovascular disease","volume":"8","author":"Morrow","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2023.09.012_bib99","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0038-1650232","article-title":"Proteins of the fibrinolytic system in human thrombi","volume":"75","author":"Robbie","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-0038-1648388","article-title":"The amount of plasminogen, tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in human thrombi and the relation to ex-vivo lysibility","volume":"67","author":"Potter van Loon","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib101","first-page":"22","article-title":"Role of shear stress and tPA concentration in the fibrinolytic potential of thrombi","author":"Whyte","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2023.09.012_bib102","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1055\/s-0038-1656041","article-title":"In\u00a0vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters","volume":"77","author":"Colucci","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib103","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1055\/s-0038-1653798","article-title":"On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasma","volume":"73","author":"Huisman","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib104","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jvs.2009.06.047","article-title":"Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis","volume":"50","author":"Humphries","year":"2009","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jtha.2023.09.012_bib105","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.09.012_bib106","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/S0021-9258(19)81051-7","article-title":"Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin","volume":"257","author":"Hoylaerts","year":"1982","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib107","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1172\/JCI113394","article-title":"Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained","volume":"81","author":"Pannell","year":"1988","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.09.012_bib108","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1073\/pnas.93.12.5899","article-title":"Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator","volume":"93","author":"Bugge","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2023.09.012_bib109","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.CIR.0000050149.22928.39","article-title":"Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells","volume":"107","author":"Singh","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2023.09.012_bib110","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1186\/s13063-022-06596-z","article-title":"Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial","volume":"23","author":"van der Ende","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.jtha.2023.09.012_bib111","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.123.064053","article-title":"Shorter door-to-needle times are associated with better outcomes after intravenous thrombolytic therapy and endovascular thrombectomy for acute ischemic stroke","volume":"148","author":"Man","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2023.09.012_bib112","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1161\/hs0901.095408","article-title":"Acute tissue damage after injections\u00a0of\u00a0thrombin and plasmin into rat striatum","volume":"32","author":"Xue","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2023.09.012_bib113","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nm0298-228","article-title":"Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice","volume":"4","author":"Wang","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2023.09.012_bib114","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/bjh.14255","article-title":"Bleeding related to disturbed fibrinolysis","volume":"175","author":"Kolev","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.09.012_bib115","article-title":"Fibrinolytic and Non-fibrinolytic roles of tissue-type plasminogen activator in the ischemic brain","author":"Yepes","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.jtha.2023.09.012_bib116","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/jcbfm.2014.99","article-title":"Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?","volume":"34","author":"Niego","year":"2014","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.jtha.2023.09.012_bib117","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular mechanisms of fibrinolysis","volume":"129","author":"Cesarman-Maus","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.09.012_bib118","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V97.12.3691","article-title":"Wound-healing defects in mice lacking fibrinogen","volume":"97","author":"Drew","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib119","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2353\/ajpath.2006.050372","article-title":"Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair","volume":"168","author":"Roth","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtha.2023.09.012_bib120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0002-9343(00)00380-6","article-title":"Third-generation thrombolytic drugs","volume":"109","author":"Verstraete","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2023.09.012_bib121","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/heart.89.11.1358","article-title":"Thrombolysis: newer thrombolytic agents and their role in clinical medicine","volume":"89","author":"Nordt","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.jtha.2023.09.012_bib122","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1073\/pnas.91.9.3670","article-title":"A\u00a0faster-acting and more potent form of tissue plasminogen activator","volume":"91","author":"Keyt","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2023.09.012_bib123","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(22)01054-6","article-title":"Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial","volume":"400","author":"Menon","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.09.012_bib124","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/jth.15806","article-title":"The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1","volume":"20","author":"Whyte","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib125","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3389\/fimmu.2018.01218","article-title":"Plasminogen activator inhibitor 1 for predicting sepsis severity and mortality outcomes: a systematic review and meta-analysis","volume":"9","author":"Tipoe","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2023.09.012_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201700954","article-title":"Enhanced fibrinolysis with magnetically powered colloidal microwheels","volume":"13","author":"Tasci","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.jtha.2023.09.012_bib127","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/jth.15617","article-title":"Breaking the fibrinolytic speed limit with microwheel co-delivery of tissue plasminogen activator and plasminogen","volume":"20","author":"Disharoon","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib128","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.763085","article-title":"Thrombus-targeting polymeric nanocarriers and their biomedical applications in thrombolytic therapy","volume":"12","author":"Guan","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jtha.2023.09.012_bib129","article-title":"Accelerating thrombolysis using a precision and clot-penetrating drug delivery strategy by nanoparticle-shelled microbubbles","volume":"6","author":"Wang","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.jtha.2023.09.012_bib130","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1126\/science.1217815","article-title":"Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels","volume":"337","author":"Korin","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jtha.2023.09.012_bib131","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/bloodadvances.2021006691","article-title":"Platelet-targeted thrombolysis for treatment of acute ischemic stroke","volume":"7","author":"Palazzolo","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.09.012_bib132","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jtha.2022.11.037","article-title":"Direct delivery of plasmin using clot-anchoring thrombin-responsive nanoparticles for targeted fibrinolytic therapy","volume":"21","author":"Sun","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib133","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1160\/TH14-08-0669","article-title":"DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment","volume":"113","author":"Varju","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100178","article-title":"Thrombus composition and thrombolysis resistance in stroke","volume":"7","author":"Ho-Tin-Noe","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.24993","article-title":"Neutrophil extracellular traps in ischemic stroke thrombi","volume":"82","author":"Laridan","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jtha.2023.09.012_bib136","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/STROKEAHA.117.019896","article-title":"Thrombus neutrophil extracellular traps content impair tPA-induced thrombolysis in acute ischemic stroke","volume":"49","author":"Ducroux","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2023.09.012_bib137","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/blood.2021011776","article-title":"Microlyse: a thrombolytic agent that targets VWF for clearance of microvascular thrombosis","volume":"139","author":"de Maat","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib138","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood.2022016342","article-title":"VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models","volume":"140","author":"van Moorsel","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.09.012_bib139","article-title":"Platelet-targeted thrombolysis for treatment of acute ischemic stroke","author":"Palazzolo","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.09.012_bib140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2302\/kjm.11.105","article-title":"A\u00a0new potent antifibrinolytic substance and its effects on blood of animals","volume":"11","author":"Okamoto","year":"1962","journal-title":"Keio J Med"},{"key":"10.1016\/j.jtha.2023.09.012_bib141","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.09.012_bib142","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial","volume":"394","author":"CRASH-3","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.09.012_bib143","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Collaborators","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.09.012_bib144","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1606424","article-title":"Network AIotACT. Tranexamic acid in patients undergoing coronary-artery surgery","volume":"376","author":"Myles","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.09.012_bib145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa2215457","article-title":"Prehospital tranexamic acid for severe trauma","volume":"389","author":"Investigators","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.09.012_bib146","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/ced.14115","article-title":"The emerging importance of tranexamic acid in dermatology","volume":"45","author":"Forbat","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jtha.2023.09.012_bib147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131216","article-title":"Dendritic cell-mediated phagocytosis but not immune activation is enhanced by plasmin","volume":"10","author":"Borg","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2023.09.012_bib148","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1189\/jlb.0212056","article-title":"Plasmin as a proinflammatory cell activator","volume":"92","author":"Syrovets","year":"2012","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jtha.2023.09.012_bib149","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/bloodadvances.2019000092","article-title":"Tranexamic acid modulates the immune response and reduces postsurgical infection rates","volume":"3","author":"Draxler","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.09.012_bib150","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MBC.0000000000000938","article-title":"Tranexamic acid is associated with reduced complement activation in trauma patients with hemorrhagic shock and hyperfibrinolysis on thromboelastography","volume":"31","author":"Barrett","year":"2020","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2023.09.012_bib151","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/ans.15538","article-title":"Influence of tranexamic acid on the complement system in trauma","volume":"90","author":"Barrett","year":"2020","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.jtha.2023.09.012_bib152","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.febslet.2009.06.013","article-title":"Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors)","volume":"583","author":"Gebbink","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jtha.2023.09.012_bib153","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nm0295-138","article-title":"In\u00a0vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues","volume":"1","author":"Kingston","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2023.09.012_bib154","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0049-3848(97)00006-6","article-title":"Amyloid beta peptides stimulate tissue-type plasminogen activator but not recombinant prourokinase","volume":"85","author":"Wnendt","year":"1997","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.09.012_bib155","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1161\/STROKEAHA.120.033107","article-title":"Cerebral amyloid angiopathy and the fibrinolytic system: is plasmin a therapeutic target?","volume":"52","author":"Mutimer","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2023.09.012_bib156","first-page":"312","article-title":"PAI-1 antagonists: the promise and the peril","volume":"122","author":"Vaughan","year":"2011","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.jtha.2023.09.012_bib157","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/jcem.86.2.7410","article-title":"Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance","volume":"86","author":"Hadigan","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jtha.2023.09.012_bib158","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.diabres.2008.02.006","article-title":"The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients","volume":"81","author":"Ersoy","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jtha.2023.09.012_bib159","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1161\/01.CIR.0000105765.54573.60","article-title":"Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass","volume":"108","author":"Pretorius","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2023.09.012_bib160","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/hr.2011.137","article-title":"Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome","volume":"34","author":"Fogari","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jtha.2023.09.012_bib161","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/jth.14716","article-title":"Molecular mechanism of two nanobodies that inhibit PAI-1 activity reveals a modulation at distinct stages of the PAI-1\/plasminogen activator interaction","volume":"18","author":"Sillen","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib162","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/s41598-019-38842-x","article-title":"Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1","volume":"9","author":"Vousden","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2023.09.012_bib163","doi-asserted-by":"crossref","first-page":"44912","DOI":"10.1074\/jbc.M103077200","article-title":"The distal hinge of the reactive site loop and its proximity: a target to modulate plasminogen activator inhibitor-1 activity","volume":"276","author":"Bijnens","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib164","doi-asserted-by":"crossref","first-page":"43858","DOI":"10.1074\/jbc.M204110200","article-title":"Mechanisms of conversion of plasminogen activator inhibitor 1 from a suicide inhibitor to a substrate by monoclonal antibodies","volume":"277","author":"Komissarov","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib165","doi-asserted-by":"crossref","first-page":"17511","DOI":"10.1074\/jbc.274.25.17511","article-title":"Accelerated conversion of human plasminogen activator inhibitor-1 to its latent form by antibody binding","volume":"274","author":"Verhamme","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib166","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.622473","article-title":"Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and inhibition","volume":"7","author":"Sillen","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2023.09.012_bib167","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1021\/jm049766q","article-title":"Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, and preclinical characterization","volume":"47","author":"Elokdah","year":"2004","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib168","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/j.1538-7836.2008.03137.x","article-title":"Bispecific targeting of thrombin activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 by a heterodimer diabody","volume":"6","author":"Develter","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.09.012_bib169","first-page":"21","article-title":"Structural insights into the mechanism of a nanobody that stabilizes PAI-1 and modulates its activity","author":"Sillen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2023.09.012_bib170","unstructured":"Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19. Trial identifier NCT04634799."},{"key":"10.1016\/j.jtha.2023.09.012_bib171","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","article-title":"Epidemiologic and molecular prognostic review of glioblastoma","volume":"23","author":"Thakkar","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jtha.2023.09.012_bib172","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41419-019-1986-2","article-title":"ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K\/AKT pathway in glioma","volume":"10","author":"Xi","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jtha.2023.09.012_bib173","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1074\/jbc.RA118.004885","article-title":"Dual-reporter high-throughput screen for small-molecule in\u00a0vivo inhibitors of plasminogen activator inhibitor type-1 yields a clinical lead candidate","volume":"294","author":"Reinke","year":"2019","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.09.012_bib174","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/CIRCULATIONAHA.116.024421","article-title":"Releasing the brakes on the fibrinolytic system in pulmonary emboli: unique effects of plasminogen activation and alpha2-antiplasmin inactivation","volume":"135","author":"Singh","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2023.09.012_bib175","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/oxfordjournals.eurheartj.a060341","article-title":"Rate of fibrinogen breakdown related to coronary patency and bleeding complications in patients with thrombolysis in acute myocardial infarction--results from the PRIMI trial","volume":"13","author":"Ostermann","year":"1992","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2023.09.012_bib176","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020883","article-title":"Carboxypeptidase U (CPU, TAFIa, CPB2) in thromboembolic disease: what do we know three decades after its discovery?","volume":"22","author":"Claesen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2023.09.012_bib177","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood-2014-07-588319","article-title":"Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke","volume":"125","author":"Wyseure","year":"2015","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623007146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623007146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:39:09Z","timestamp":1761536349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623007146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":177,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1538783623007146"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.09.012","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The fibrinolysis renaissance","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}